ໜ້າທຳອິດNATCOPHARM • NSE
add
Natco Pharma Ltd.
ປິດກ່ອນໜ້າ
₹1.389,20
ຂອບເຂດລາຄາໃນມື້
₹1.365,60 - ₹1.403,85
ຂອບເຂດລາຄາໃນປີ
₹724,20 - ₹1.639,00
ມູນຄ່າຮຸ້ນຕາມລາຄາຕະຫຼາດ
250,57 ຕື້ INR
ປະລິມານສະເລ່ຍ
843,82 ກີບ
ອັດຕາ P/E
15,31
ເງິນປັນຜົນ
0,39%
ຕະຫຼາດຂັ້ນຕົ້ນ
NSE
ຂ່າວຕະຫຼາດ
ການເງິນ
ໃບລາຍງານຜົນໄດ້ຮັບ
ລາຍໄດ້
ລາຍໄດ້ສຸດທິ
(INR) | ມິ.ຖ. 2024info | ການປ່ຽນແປງ ປ/ປ |
---|---|---|
ລາຍໄດ້ | 13,63 ຕື້ | 19,47% |
ຄ່າໃຊ້ຈ່າຍການດຳເນີນການ | 4,22 ຕື້ | 3,11% |
ລາຍໄດ້ສຸດທິ | 6,68 ຕື້ | 59,05% |
ສ່ວນແບ່ງກຳໄລສຸດທິ | 49,06 | 33,13% |
ລາຍໄດ້ຕໍ່ຮຸ້ນ | 37,32 | 60,45% |
EBITDA | 8,07 ຕື້ | 40,06% |
ອັດຕາອາກອນທີ່ມີຜົນ | 16,81% | — |
ໃບດຸ່ນດ່ຽງ
ຊັບສິນທັງໝົດ
ໜີ້ສິນທັງໝົດ
(INR) | ມິ.ຖ. 2024info | ການປ່ຽນແປງ ປ/ປ |
---|---|---|
ເງິນສົດ ແລະ ລົງທຶນໄລຍະສັ້ນ | 18,49 ຕື້ | 59,13% |
ຊັບສິນທັງໝົດ | — | — |
ໜີ້ສິນທັງໝົດ | — | — |
ຫຸ້ນທຶນທັງໝົດ | 58,53 ຕື້ | — |
ຮຸ້ນທີ່ຄ້າງຈ່າຍ | 179,13 ລ້ານ | — |
ລາຄາຕໍ່ມູນຄ່າທາງບັນຊີ | 4,25 | — |
ລາຍຮັບຈາກຊັບສິນ | — | — |
ລາຍຮັບຈາກທຶນ | 30,55% | — |
ກະແສເງິນສົດ
ການປ່ຽນແປງສຸດທິເປັນເງິນສົດ
(INR) | ມິ.ຖ. 2024info | ການປ່ຽນແປງ ປ/ປ |
---|---|---|
ລາຍໄດ້ສຸດທິ | 6,68 ຕື້ | 59,05% |
ເງິນສົດຈາກການດໍາເນີນງານ | — | — |
ເງິນສົດຈາກການລົງທຶນ | — | — |
ເງິນສົດຈາກການເງິນ | — | — |
ການປ່ຽນແປງສຸດທິເປັນເງິນສົດ | — | — |
ການເງິນສະພາບຄ່ອງ | — | — |
ກ່ຽວກັບ
Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad with a presence in formulation and active pharmaceutical ingredients in both domestic and international markets. The company also manufactures Agro chemical products. It is a major producer of branded oncology medicines cardiology, diabetology and other pharma specialty drugs. The company specialises in producing complex medicines at affordable prices. The company has a presence in 50+ countries. NATCO is a science driven company and focuses on limited competition molecules in the US .The company’s pharma division has 5 manufacturing facilities, 2 API and intermediate manufacturing facilities and the crop health sciences division has one formulation and one technical manufacturing facility. The company boasts of having a talent pool of 450+ scientists working out of two research centers in India.
Across the globe, cancer treatment saw a sea change in early 2000s in terms of screening, diagnosis, molecular pathology, targeted therapies, immunotherapies, Bone Marrow Transplants, and supportive care. Wikipedia
ສ້າງຕັ້ງ
1981
ສໍານັກງານໃຫຍ່
ເວັບໄຊ
ພະນັກງານ
4.016